In Ireland, to date, coronary thrombolytic therapy has been confined almost exclusively to the use of streptokinase. However, a large body of evidence suggests that, in comparison to streptokinase, the agent recombinant tissue-type plasminogen activator (rt-PA) may be more effective in lysing coronary thrombi and achieving coronary reperfusion and causes fewer disturbances of the coagulation sy...

OBJECTIVES We sought to assess the efficacy and safety of thrombolytic therapy in patients with an acute pulmonary embolism (PE). BACKGROUND Thrombolytic therapy is approved for the treatment of acute PE; however, the safety and efficacy of this therapy remain debated. METHODS A meta-analysis of randomized, controlled trials comparing thrombolytic agents with intravenous heparin in patients...

background: the use of thrombolytic agents in the treatment of hemodynamically stable patients with acute submassive pulmonary embolism (pte) remains controversial. we, therefore, conducted this study to compare the effect of thrombolytic plus anticoagulation versus anticoagulation alone on early death and adverse outcome following submassive pte. methods: w e conducted a study of patients with...

The scientists William S. Tillett and Sol Sherry were responsible for the introduction of intrapleural fibrinolytics as therapeutic agents, thus supplementing antimicrobial therapy in the treatment of empyema. They were the first to suggest the possibility that the use of these drugs in empyema might obviate the need for radical surgical procedures. This article highlights their original work a...

Background and Objective: Acute myocardial infarction (MI) is caused due to coronary artery occlusion and divided into two forms of ST-elevation (STEMI) and non-ST-elevation (NSTEMI) myocardial infarction. This study aimed to determine the success rate of treatment with primary PCI (percutaneous coronary intervention) versus thrombolysis in the establishment of perfusion and to evaluate the sho...

A diimmistration of a variety of noonfibrinolytic, noanenizymImatic substances imdluces fibrinmolvsis in moan. The most potent materials of this type known at present are purified protein-fre( pyrogenms. Their action after intravenous injection on the huiman fibrinolytic system, on some of its componemIts, and on the clotting system of 67 individuals has been studied. The possible therapeutic i...

BACKGROUND Atherothrombotic diseases such as myocardial or cerebral infarction are serious consequences of the thrombus formed in blood vessels. Thrombolytic agents are used to dissolve the already formed clots in the blood vessels; however, these drugs have certain limitations which cause serious and sometimes fatal consequences. Herbal preparations have been used since ancient times for the t...

Indlvldual studies of patency rates and left ventricular (LV) function after thrombolysis have generally been limited by small numbers of observations, wide confidence intervals, and limRed numbers of time points. To obtain a more reliable estimate of patterns of patency and LV ejection fraction, a systematic overview of anglographic studies was performed after itira= venous thrombolytic therap...